Deva Holding AS Market Cap ($310.23 Million)
Market Cap & Net Worth: Deva Holding AS (DEVA)
Deva Holding AS market cap. Deva Holding AS (IS:DEVA) has a market capitalization of $310.23 Million (TL13.85 Billion) as of October 31, 2026. Listed on the IS stock exchange, this Turkey-based company holds position #14347 globally and #104 in its home market, demonstrating a -5.97% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Deva Holding AS's stock price TL69.25 by its total outstanding shares 200019288 (200.02 Million).
Deva Holding AS Market Cap History (2015–2026)
Deva Holding AS market cap history from 2015 to 2026. Data shows growth from $17.01 Million to $310.23 Million (30.62% CAGR). Check today's stock price for Deva Holding AS for real-time trading data and today's change.
Deva Holding AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Deva Holding AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Deva Holding AS cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.02x
Deva Holding AS's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.06x
Deva Holding AS's market cap is 5.06 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $17.01 Million | $576.38 Million | $47.66 Million | 0.03x | 0.36x |
| 2016 | $15.43 Million | $688.46 Million | $60.33 Million | 0.02x | 0.26x |
| 2017 | $19.20 Million | $800.30 Million | $92.54 Million | 0.02x | 0.21x |
| 2018 | $14.42 Million | $1.04 Billion | $136.36 Million | 0.01x | 0.11x |
| 2019 | $39.40 Million | $1.37 Billion | $286.02 Million | 0.03x | 0.14x |
| 2020 | $106.55 Million | $1.86 Billion | $651.45 Million | 0.06x | 0.16x |
| 2021 | $127.28 Million | $2.33 Billion | $1.17 Billion | 0.05x | 0.11x |
| 2022 | $307.92 Million | $4.48 Billion | $1.36 Billion | 0.07x | 0.23x |
| 2023 | $337.44 Million | $16.36 Billion | $4.89 Billion | 0.02x | 0.07x |
| 2024 | $351.23 Million | $15.46 Billion | $69.42 Million | 0.02x | 5.06x |
Competitor Companies of DEVA by Market Capitalization
Companies near Deva Holding AS in the global market cap rankings as of October 31, 2026. See DEVA net asset quality score to understand what proportion of total assets are financed by equity.
Key companies related to Deva Holding AS by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Deva Holding AS (2015–2026)
Market capitalization of Deva Holding AS from 2015 to today. Between 2015 and today, Deva Holding AS's market cap moved from $17.01 Million to $ 310.23 Million, with a yearly change of 30.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | TL310.23 Million | +10.45% |
| 2025 | TL280.89 Million | -20.03% |
| 2024 | TL351.23 Million | +4.08% |
| 2023 | TL337.44 Million | +9.59% |
| 2022 | TL307.92 Million | +141.92% |
| 2021 | TL127.28 Million | +19.46% |
| 2020 | TL106.55 Million | +170.39% |
| 2019 | TL39.40 Million | +173.25% |
| 2018 | TL14.42 Million | -24.89% |
| 2017 | TL19.20 Million | +24.43% |
| 2016 | TL15.43 Million | -9.28% |
| 2015 | TL17.01 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Deva Holding AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $310.23 Million USD |
| MoneyControl | $310.23 Million USD |
| MarketWatch | $310.23 Million USD |
| marketcap.company | $310.23 Million USD |
| Reuters | $310.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Deva Holding AS
Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and … Read more